Categories: BioTechBuildingCareEngineeringFutureHealthTech
Armatus Bio is engineering the future of precision therapies to transform outcomes for patients and our communities.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.05.2025 | - | $3M | - |
Mentions in press and media 5
| Date | Title | Description |
| 06.05.2025 | Armatus Bio Receives $3M Investment from SOLVE FSHD | Armatus Bio, a Columbus, OH-based biotechnology company developing new vectorized RNAi therapeutics for neuromuscular diseases, received a $3M investment from SOLVE FSHD.
The company intends to use the funds to support ARM-201, its AAV-deli... |
| 27.03.2025 | Leading Scientists and Advocates Unite for 'OHio, What a Night' to Accelerate Charcot-Marie-Tooth Disease Research | CMT Research Foundation Hosts Exclusive Event Spotlighting Groundbreaking Advances in CMT Treatment in Columbus COLUMBUS, OH, UNITED STATES, March 27, 2025 /EINPresswire.com/ -- The CMT Research Foundation is bringing together world-renowne... |
| 07.03.2024 | Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD | - |
| 24.10.2023 | CMT Research Foundation Invests in Armatus Bio, Inc. to Advance Potential Therapeutic for CMT1A | CMT Research Foundation ATLANTA, GA, USA, October 24, 2023 /EINPresswire.com/ -- The CMT Research Foundation, a non-profit focused solely on delivering treatments and cures for Charcot-Marie-Tooth disease (CMT)*, has invested in a project a... |
| - | Armatus Bio | “Armatus Bio is raising expectations for FSHD with precision gene therapy.” |
Reviews 0
